Skip to main content

Table 1 (abstract P193). Treatment groups

From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Group

Treatment

Group 1 (Red)

Control Chow + IP 2A3 + IT PBS

Group 2 (Orange)

BRAFi Chow + IP 2A3 + IT PBS

Group 3 (Yellow)

BRAFi Chow + Ip α-PD1 + IT PBS

Group 4 (Green)

BRAFi Chow + IP 2A3 + IT T-Vec

Group 5 (Blue)

BRAFi Chow + IP α-PD1 + IT T-Vec

Group 6 (Purple)

Control Chow + IP α=PD1 + IT T-Vec

  1. IP intraperitoneal, IT intratumoral, BRAFi brief inhibiotor, α-PD1 anti programmed cell death 1, T-Vec talimogene Leherparepvec